Concepedia

Weining Weng

WW

Statistics

Publications

6

Citations

199

H-Index

6

Active since

2020

Affiliations

Northwest University(Current)

Sun Yat-sen University

Forma Therapeutics (United States)

Regend Therapeutics (China)

Guangdong Pharmaceutical University

Weining Weng is an author at Northwest University specializing in oncology, antibody-drug conjugate therapy, and targeted therapy.

Publications per year

2020–2023

6

Publications

6

Antibody–Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer

Weining Weng, Tao Meng, Qianqian Zhao et al. · Cancer Discovery · 2023 · 76 citations

Pharmacy, Oncology, Pharmacology +17

An array of 60,000 antibodies for proteome-scale antibody generation and target discovery

Zhaohui Wang, Yang Li, Bing Hou et al. · Science Advances · 2020 · 37 citations · Full text

Pharmacy, Biotechnology, Molecular Biology +17

Application of an antibody chip for screening differentially expressed proteins during peach ripening and identification of a metabolon in the SAM cycle to generate a peach ethylene biosynthesis model

Wenfang Zeng, Liang Niu, Zhaohui Wang et al. · Horticulture Research · 2020 · 31 citations · Full text

Agriculture, Biochemistry, Crop Sciences +17

AMT-562, a Novel HER3-targeting Antibody–Drug Conjugate, Demonstrates a Potential to Broaden Therapeutic Opportunities for HER3-expressing Tumors

Weining Weng, Tao Meng, Junyi Pu et al. · Molecular Cancer Therapeutics · 2023 · 26 citations · Full text

Medicine, Oncology, Pharmacology +17

A Cell Surface-Binding Antibody Atlas Nominates a MUC18-Directed Antibody–Drug Conjugate for Targeting Melanoma

Jing Shi, Tao Jiao, Qian Guo et al. · Cancer Research · 2023 · 15 citations · Full text

Medicine, Oncology, Pharmacology +16

1–5 of 6